Danish educational materials

02 February 2023

From November 15th 2016 the Danish Medicines Agency published Danish educational materials for human medicinal products approved via the national procedure, the mutual recognition procedure and the decentralised procedure.

From January 1st 2023 and forward – and not retroactively - the Danish Medicines Agency also publishes Danish educational materials for human medicinal products approved via the centralised procedure.

The marketing authorisation holder has the overall responsibility for the educational material and for ensuring that it complies with the conditions of the marketing authorisation. The marketing authorisation holder also has the overall responsibility for ensuring that the Danish Medicines Agency has the latest accepted written educational material available for publication.

Please refer to the section Dansk uddannelsesmateriale for the accepted and published Danish educational materials 

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å 0-9
Va-Vd Ve-Vh Vi-Vl Vm-Vp Vq-Vu Vv-Vz Væ-Vå
Name Medicine Type Strength Active substance Mft owner Publish Date
Velsipity filmovertrukne tabletter 2 mg Etrasimodarginin Pfizer Europe MA EEIG 26/08/2024
Ventizolve næsespray, opløsning i enkeltdosisbeholder 1,26 mg/dosis NALOXONHYDROCHLORID (vandfrit) dne pharma as 15/11/2024
Vfend filmovertrukne tabletter 50 mg VORICONAZOL Pfizer Europe MA EEIG 20/09/2024
Vfend filmovertrukne tabletter 200 mg VORICONAZOL Pfizer Europe MA EEIG 20/09/2024
Vfend pulver og solvens til infusionsvæske, opløsning 200 mg VORICONAZOL Pfizer Europe MA EEIG 20/09/2024
Vfend pulver til infusionsvæske, opløsning 200 mg VORICONAZOL Pfizer Europe MA EEIG 20/09/2024
Vfend pulver til oral suspension 40 mg/ml VORICONAZOL Pfizer Europe MA EEIG 20/09/2024